XPAD European Feasibility Study

A prospective, single arm, non-randomized European feasibility study to evaluate the safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective lower-limb, above or below the knee, bypass surgery.

NCT Number	NCT07716020
Lead Sponsor	Xeltis
Conditions	Peripheral Arterial Disease
Enrollment	15 participants
Start Date	2026-12
Primary Completion	2028-12 (estimated)
Study Completion	2032-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-21